193 related articles for article (PubMed ID: 12438241)
1. Sequence variants of alpha-methylacyl-CoA racemase are associated with prostate cancer risk.
Zheng SL; Chang BL; Faith DA; Johnson JR; Isaacs SD; Hawkins GA; Turner A; Wiley KE; Bleecker ER; Walsh PC; Meyers DA; Isaacs WB; Xu J
Cancer Res; 2002 Nov; 62(22):6485-8. PubMed ID: 12438241
[TBL] [Abstract][Full Text] [Related]
2. Sequence variants of alpha-methylacyl-CoA racemase are associated with prostate cancer risk: a replication study in an ethnically homogeneous population.
FitzGerald LM; Thomson R; Polanowski A; Patterson B; McKay JD; Stankovich J; Dickinson JL
Prostate; 2008 Sep; 68(13):1373-9. PubMed ID: 18537123
[TBL] [Abstract][Full Text] [Related]
3. Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer.
Luo J; Zha S; Gage WR; Dunn TA; Hicks JL; Bennett CJ; Ewing CM; Platz EA; Ferdinandusse S; Wanders RJ; Trent JM; Isaacs WB; De Marzo AM
Cancer Res; 2002 Apr; 62(8):2220-6. PubMed ID: 11956072
[TBL] [Abstract][Full Text] [Related]
4. Sequence variation in alpha-methylacyl-CoA racemase and risk of early-onset and familial prostate cancer.
Levin AM; Zuhlke KA; Ray AM; Cooney KA; Douglas JA
Prostate; 2007 Oct; 67(14):1507-13. PubMed ID: 17683075
[TBL] [Abstract][Full Text] [Related]
5. Branched fatty acids in dairy and beef products markedly enhance alpha-methylacyl-CoA racemase expression in prostate cancer cells in vitro.
Mobley JA; Leav I; Zielie P; Wotkowitz C; Evans J; Lam YW; L'Esperance BS; Jiang Z; Ho SM
Cancer Epidemiol Biomarkers Prev; 2003 Aug; 12(8):775-83. PubMed ID: 12917210
[TBL] [Abstract][Full Text] [Related]
6. Polymorphic variants in alpha-methylacyl-CoA racemase and prostate cancer.
Daugherty SE; Shugart YY; Platz EA; Fallin MD; Isaacs WB; Pfeiffer RM; Welch R; Huang WY; Reding D; Hayes RB
Prostate; 2007 Oct; 67(14):1487-97. PubMed ID: 17680641
[TBL] [Abstract][Full Text] [Related]
7. Alternative spliced variants of the alpha-methylacyl-CoA racemase gene and their expression in prostate cancer.
Mubiru JN; Shen-Ong GL; Valente AJ; Troyer DA
Gene; 2004 Feb; 327(1):89-98. PubMed ID: 14960364
[TBL] [Abstract][Full Text] [Related]
8. Significant association of alpha-methylacyl-CoA racemase gene polymorphisms with susceptibility to prostate cancer: a meta-analysis.
Chen N; Wang JR; Huang L; Yang Y; Jiang YM; Guo XJ; He YZ; Zhou YH
Asian Pac J Cancer Prev; 2015; 16(5):1857-63. PubMed ID: 25773837
[TBL] [Abstract][Full Text] [Related]
9. A nonclassic CCAAT enhancer element binding protein binding site contributes to alpha-methylacyl-CoA racemase expression in prostate cancer.
Zha S; Isaacs WB
Mol Cancer Res; 2005 Feb; 3(2):110-8. PubMed ID: 15755877
[TBL] [Abstract][Full Text] [Related]
10. A variant of the alpha-methyl-acyl-CoA racemase gene created by a deletion in exon 5 and its expression in prostate cancer.
Mubiru JN; Valente AJ; Troyer DA
Prostate; 2005 Oct; 65(2):117-23. PubMed ID: 15880524
[TBL] [Abstract][Full Text] [Related]
11. Chromosome 8q24 risk variants in hereditary and non-hereditary prostate cancer patients.
Sun J; Lange EM; Isaacs SD; Liu W; Wiley KE; Lange L; Gronberg H; Duggan D; Carpten JD; Walsh PC; Xu J; Chang BL; Isaacs WB; Zheng SL
Prostate; 2008 Apr; 68(5):489-97. PubMed ID: 18213635
[TBL] [Abstract][Full Text] [Related]
12. Variants in the alpha-Methylacyl-CoA racemase gene and the association with advanced distal colorectal adenoma.
Daugherty SE; Platz EA; Shugart YY; Fallin MD; Isaacs WB; Chatterjee N; Welch R; Huang WY; Hayes RB
Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1536-42. PubMed ID: 17684125
[TBL] [Abstract][Full Text] [Related]
13. Joint effect of HSD3B1 and HSD3B2 genes is associated with hereditary and sporadic prostate cancer susceptibility.
Chang BL; Zheng SL; Hawkins GA; Isaacs SD; Wiley KE; Turner A; Carpten JD; Bleecker ER; Walsh PC; Trent JM; Meyers DA; Isaacs WB; Xu J
Cancer Res; 2002 Mar; 62(6):1784-9. PubMed ID: 11912155
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of SRD5A2 sequence variants in susceptibility to hereditary and sporadic prostate cancer.
Chang BL; Zheng SL; Isaacs SD; Turner AR; Bleecker ER; Walsh PC; Meyers DA; Isaacs WB; Xu J
Prostate; 2003 Jun; 56(1):37-44. PubMed ID: 12746845
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of alpha-methylacyl-coenzyme A racemase in colorectal carcinoma bears clinical and pathologic significance.
Lin A; Weiser MR; Klimstra DS; Paty PB; Tang LH; Al-Ahmadie H; Hoo Park S; Guillem JG; Temple L; Wong WD; Gerald WL; Shia J
Hum Pathol; 2007 Jun; 38(6):850-6. PubMed ID: 17442371
[TBL] [Abstract][Full Text] [Related]
16. Alpha-methylacyl-CoA racemase as an androgen-independent growth modifier in prostate cancer.
Zha S; Ferdinandusse S; Denis S; Wanders RJ; Ewing CM; Luo J; De Marzo AM; Isaacs WB
Cancer Res; 2003 Nov; 63(21):7365-76. PubMed ID: 14612535
[TBL] [Abstract][Full Text] [Related]
17. Expression profiling identifies a novel alpha-methylacyl-CoA racemase exon with fumarate hydratase homology.
Shen-Ong GL; Feng Y; Troyer DA
Cancer Res; 2003 Jun; 63(12):3296-301. PubMed ID: 12810662
[TBL] [Abstract][Full Text] [Related]
18. Kinetic fluorescence reverse transcriptase-polymerase chain reaction for alpha-methylacyl CoA racemase distinguishes prostate cancer from benign lesions.
Schostak M; Miller K; Krause H; Schrader M; Kempkensteffen C; Kollermann J
Cancer Detect Prev; 2006; 30(5):449-54. PubMed ID: 17067752
[TBL] [Abstract][Full Text] [Related]
19. A novel diagnostic test for prostate cancer emerges from the determination of alpha-methylacyl-coenzyme a racemase in prostatic secretions.
Zielie PJ; Mobley JA; Ebb RG; Jiang Z; Blute RD; Ho SM
J Urol; 2004 Sep; 172(3):1130-3. PubMed ID: 15311056
[TBL] [Abstract][Full Text] [Related]
20. Alpha-methylacyl-CoA racemase: a multi-institutional study of a new prostate cancer marker.
Jiang Z; Wu CL; Woda BA; Iczkowski KA; Chu PG; Tretiakova MS; Young RH; Weiss LM; Blute RD; Brendler CB; Krausz T; Xu JC; Rock KL; Amin MB; Yang XJ
Histopathology; 2004 Sep; 45(3):218-25. PubMed ID: 15330799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
